434 related articles for article (PubMed ID: 19124382)
41. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
42. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
[TBL] [Abstract][Full Text] [Related]
43. Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.
Mei D; Tan WSD; Liao W; Heng CKM; Wong WSF
Pharmacol Res; 2020 Nov; 161():105223. PubMed ID: 33017650
[TBL] [Abstract][Full Text] [Related]
44. Glutathione peroxidase-1 as a novel therapeutic target for COPD.
Vlahos R; Bozinovski S
Redox Rep; 2013; 18(4):142-9. PubMed ID: 23849338
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
46. Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope?
Beijers RJHCG; Gosker HR; Schols AMWJ
Curr Opin Clin Nutr Metab Care; 2018 Mar; 21(2):138-144. PubMed ID: 29200030
[TBL] [Abstract][Full Text] [Related]
47. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.
Kinnula VL
Thorax; 2005 Aug; 60(8):693-700. PubMed ID: 16061713
[TBL] [Abstract][Full Text] [Related]
48. Protective effects of liquiritin apioside on cigarette smoke-induced lung epithelial cell injury.
Guan Y; Li FF; Hong L; Yan XF; Tan GL; He JS; Dong XW; Bao MJ; Xie QM
Fundam Clin Pharmacol; 2012 Aug; 26(4):473-83. PubMed ID: 21631586
[TBL] [Abstract][Full Text] [Related]
49. Recuperating lung decoction attenuates inflammation and oxidation in cigarette smoke-induced COPD in rats via activation of ERK and Nrf2 pathways.
Li C; Yan Y; Shi Q; Kong Y; Gao L; Bao H; Li Y
Cell Biochem Funct; 2017 Jul; 35(5):278-286. PubMed ID: 28749079
[TBL] [Abstract][Full Text] [Related]
50. Environmental toxicity, redox signaling and lung inflammation: the role of glutathione.
Biswas SK; Rahman I
Mol Aspects Med; 2009; 30(1-2):60-76. PubMed ID: 18760298
[TBL] [Abstract][Full Text] [Related]
51. Ursolic acid attenuates cigarette smoke-induced emphysema in rats by regulating PERK and Nrf2 pathways.
Lin L; Yin Y; Hou G; Han D; Kang J; Wang Q
Pulm Pharmacol Ther; 2017 Jun; 44():111-121. PubMed ID: 28347799
[TBL] [Abstract][Full Text] [Related]
52. Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells.
Tan WSD; Liao W; Peh HY; Vila M; Dong J; Shen HM; Wong WSF
Toxicol Appl Pharmacol; 2018 Dec; 360():120-130. PubMed ID: 30291937
[TBL] [Abstract][Full Text] [Related]
53. Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers.
Aydemir Y; Aydemir Ö; Şengül A; Güngen AC; Çoban H; Taşdemir C; Düzenli H; Şehitoğulları A
Heart Lung; 2019; 48(6):566-569. PubMed ID: 31371032
[TBL] [Abstract][Full Text] [Related]
54. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.
Macnee W; Rahman I
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S58-65. PubMed ID: 10556172
[TBL] [Abstract][Full Text] [Related]
55. Role of GPx3 in PPARγ-induced protection against COPD-associated oxidative stress.
Reddy AT; Lakshmi SP; Banno A; Reddy RC
Free Radic Biol Med; 2018 Oct; 126():350-357. PubMed ID: 30118830
[TBL] [Abstract][Full Text] [Related]
56. Ergosterol attenuates cigarette smoke extract-induced COPD by modulating inflammation, oxidative stress and apoptosis
Sun X; Feng X; Zheng D; Li A; Li C; Li S; Zhao Z
Clin Sci (Lond); 2019 Jul; 133(13):1523-1536. PubMed ID: 31270147
[TBL] [Abstract][Full Text] [Related]
57. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells.
Kode A; Rajendrasozhan S; Caito S; Yang SR; Megson IL; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2008 Mar; 294(3):L478-88. PubMed ID: 18162601
[TBL] [Abstract][Full Text] [Related]
58. Trans-4,4'-dihydroxystilbene ameliorates cigarette smoke-induced progression of chronic obstructive pulmonary disease via inhibiting oxidative stress and inflammatory response.
Wang T; Dai F; Li GH; Chen XM; Li YR; Wang SQ; Ren DM; Wang XN; Lou HX; Zhou B; Shen T
Free Radic Biol Med; 2020 May; 152():525-539. PubMed ID: 31760092
[TBL] [Abstract][Full Text] [Related]
59. Oxidants in asthma and in chronic obstructive pulmonary disease (COPD).
Psarras S; Caramori G; Contoli M; Papadopoulos N; Papi A
Curr Pharm Des; 2005; 11(16):2053-62. PubMed ID: 15974958
[TBL] [Abstract][Full Text] [Related]
60. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
MacNee W
Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
